-
Je něco špatně v tomto záznamu ?
Autophagy-lysosomal pathway is involved in lipid degradation in rat liver
V. Skop, M. Cahová, Z. Papáčková, E. Páleníčková, H. Daňková, M. Baranowski, P. Zabielski, J. Zdychová, J. Zídková, L. Kazdová
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10504
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- asparagin farmakologie MeSH
- autofagie účinky léků MeSH
- chlorochin farmakologie MeSH
- diglyceridy metabolismus MeSH
- hepatocyty metabolismus patologie účinky léků MeSH
- játra metabolismus patologie účinky léků MeSH
- krysa rodu rattus MeSH
- kultivované buňky MeSH
- kyseliny mastné neesterifikované metabolismus MeSH
- lipolýza MeSH
- lipoproteiny VLDL metabolismus MeSH
- lyzozomy metabolismus patologie účinky léků MeSH
- membránový protein 2 asociovaný s lyzozomy metabolismus MeSH
- oxidace-redukce MeSH
- potkani Wistar MeSH
- proteiny asociované s mikrotubuly metabolismus MeSH
- sirolimus farmakologie MeSH
- sterolesterasa metabolismus MeSH
- triglyceridy metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
We present data supporting the hypothesis that the lysosomal-autophagy pathway is involved in the degradation of intracellular triacylglycerols in the liver. In primary hepatocytes cultivated in the absence of exogenous fatty acids (FFA), both inhibition of autophagy flux (asparagine) or lysosomal activity (chloroquine) decreased secretion of VLDL (very low density lipoproteins) and formation of FFA oxidative products while the stimulation of autophagy by rapamycine increased some of these parameters. Effect of rapamycine was completely abolished by inactivation of lysosomes. Similarly, when autophagic activity was influenced by cultivating the hepatocytes in "starving" (amino-acid poor medium) or "fed" (serum-supplemented medium) conditions, VLDL secretion and FFA oxidation mirrored the changes in autophagy being higher in starvation and lower in fed state. Autophagy inhibition as well as lysosomal inactivation depressed FFA and DAG (diacylglycerol) formation in liver slices in vitro. In vivo, intensity of lysosomal lipid degradation depends on the formation of autophagolysosomes, i.e. structures bringing the substrate for degradation and lysosomal enzymes into contact. We demonstrated that lysosomal lipase (LAL) activity in liver autophagolysosomal fraction was up-regulated in fasting and down-regulated in fed state together with the increased translocation of LAL and LAMP2 proteins from lysosomal pool to this fraction. Changes in autophagy intensity (LC3-II/LC3-I ratio) followed a similar pattern.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12035269
- 003
- CZ-PrNML
- 005
- 20141112120233.0
- 007
- ta
- 008
- 121023s2012 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932285 $2 doi
- 035 __
- $a (PubMed)22480422
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Škop, Vojtěch $7 xx0121451 $u Department of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Czech Republic
- 245 10
- $a Autophagy-lysosomal pathway is involved in lipid degradation in rat liver / $c V. Skop, M. Cahová, Z. Papáčková, E. Páleníčková, H. Daňková, M. Baranowski, P. Zabielski, J. Zdychová, J. Zídková, L. Kazdová
- 520 9_
- $a We present data supporting the hypothesis that the lysosomal-autophagy pathway is involved in the degradation of intracellular triacylglycerols in the liver. In primary hepatocytes cultivated in the absence of exogenous fatty acids (FFA), both inhibition of autophagy flux (asparagine) or lysosomal activity (chloroquine) decreased secretion of VLDL (very low density lipoproteins) and formation of FFA oxidative products while the stimulation of autophagy by rapamycine increased some of these parameters. Effect of rapamycine was completely abolished by inactivation of lysosomes. Similarly, when autophagic activity was influenced by cultivating the hepatocytes in "starving" (amino-acid poor medium) or "fed" (serum-supplemented medium) conditions, VLDL secretion and FFA oxidation mirrored the changes in autophagy being higher in starvation and lower in fed state. Autophagy inhibition as well as lysosomal inactivation depressed FFA and DAG (diacylglycerol) formation in liver slices in vitro. In vivo, intensity of lysosomal lipid degradation depends on the formation of autophagolysosomes, i.e. structures bringing the substrate for degradation and lysosomal enzymes into contact. We demonstrated that lysosomal lipase (LAL) activity in liver autophagolysosomal fraction was up-regulated in fasting and down-regulated in fed state together with the increased translocation of LAL and LAMP2 proteins from lysosomal pool to this fraction. Changes in autophagy intensity (LC3-II/LC3-I ratio) followed a similar pattern.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a asparagin $x farmakologie $7 D001216
- 650 _2
- $a autofagie $x účinky léků $7 D001343
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a chlorochin $x farmakologie $7 D002738
- 650 _2
- $a diglyceridy $x metabolismus $7 D004075
- 650 _2
- $a kyseliny mastné neesterifikované $x metabolismus $7 D005230
- 650 _2
- $a hepatocyty $x metabolismus $x patologie $x účinky léků $7 D022781
- 650 _2
- $a lipolýza $7 D008066
- 650 _2
- $a lipoproteiny VLDL $x metabolismus $7 D008079
- 650 _2
- $a játra $x metabolismus $x patologie $x účinky léků $7 D008099
- 650 _2
- $a membránový protein 2 asociovaný s lyzozomy $x metabolismus $7 D052119
- 650 _2
- $a lyzozomy $x metabolismus $x patologie $x účinky léků $7 D008247
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a proteiny asociované s mikrotubuly $x metabolismus $7 D008869
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a sirolimus $x farmakologie $7 D020123
- 650 _2
- $a sterolesterasa $x metabolismus $7 D002787
- 650 _2
- $a triglyceridy $x metabolismus $7 D014280
- 650 _2
- $a oxidace-redukce $7 D010084
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Cahová, Monika $7 xx0070633 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Papáčková, Zuzana. $7 xx0213744 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Páleníčková, Eliška. $7 xx0239890 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Daňková, Helena. $7 xx0239615 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Baranowski, M. $u Medical University of Bialystok, Poland
- 700 1_
- $a Zabielski, P. $u Medical University of Bialystok, Poland
- 700 1_
- $a Ždychová, Jana $7 xx0128624 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Zídková, Jarmila $7 xx0074470 $u Department of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Czech Republic
- 700 1_
- $a Kazdová, Ludmila, $d 1938- $7 xx0053119 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 61, č. 3 (2012), s. 287-297
- 856 41
- $u http://www.biomed.cas.cz/physiolres/archive.htm
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20141112120247 $b ABA008
- 999 __
- $a ok $b bmc $g 960119 $s 792769
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 61 $c 3 $d 287-297 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- GRA __
- $a NS10504 $p MZ0
- LZP __
- $a Pubmed-20121023-PhysRes1203BezM